Bausch Health Companies Inc.(BHC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #1,353 of 2,960 stocksTOP 50%
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
Unusual Activity in BHC
Events flagged as statistical outliers against BHC's own multi-year baseline — not fixed dollar thresholds.
BHC Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for Bausch Health Companies Inc. (BHC), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores BHC at 54.1/100 on a 32-signal composite quality model, placing it at rank #1,353 of 2,960 stocks — the top half of the AI-ranked universe. BHC scores in the top quartile across revenue scale (87.2), earnings quality (78.5). Areas of concern include profitability (18.2) and balance sheet strength (24.0), which score below median versus the broader universe. Shareholder dilution risk is elevated at 39.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Bausch Health Companies Inc. reports quarterly revenue of $2.9B, net income of $258.0M, free cash flow of $593.0M. Top institutional holders of BHC by reported 13-F value include PAULSON, GOLDENTREE ASSET MANAGEMENT, ROYAL BANK OF CANADA, based on the most recent SEC filings. BHC trades on the NYSE exchange and files with the SEC under CIK 885590. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate BHC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Bausch Health Companies Inc. directly from SEC EDGAR. Bausch Health Companies Inc.'s 13F Pro composite quality score has ranged between 38 and 64 since 2021, currently 54.1 — an improving long-term trajectory across 69 quarterly and live scoring snapshots.
Revenue
Q2 2026
$2.9B
Net Income
Q2 2026
$258.0M
Free Cash Flow
Q2 2026
$593.0M
ROIC
Q2 2026
14.9%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
+6.7% YoYNet Income
+441.3% YoYOperating Income
+17.3% YoYEPS (Diluted)
+423.1% YoYTotal Assets
-0.6% YoYTotal Debt
-13.4% YoYOp. Cash Flow
-12.3% YoYFree Cash Flow
-20.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $10.27B +6.7% | $9.63B +9.9% | $8.76B +7.8% | $8.12B -3.7% | $8.43B +5.1% | $8.03B |
| Net Income | $157.0M +441.3% | $-46.0M +92.2% | $-592.0M -163.1% | $-225.0M +76.3% | $-948.0M -69.3% | $-560.0M |
| Operating Income | $1.81B +17.3% | $1.55B +60.5% | $963.0M +112.1% | $454.0M +0.9% | $450.0M -33.4% | $676.0M |
| EPS (Diluted) | $0.42 +423.1% | $-0.13 +92.0% | $-1.62 -161.3% | $-0.62 +76.5% | $-2.64 -67.1% | $-1.58 |
| Total Assets | $26.37B -0.6% | $26.52B -3.0% | $27.35B +6.5% | $25.69B -12.0% | $29.20B -6.4% | $31.20B |
| Total Debt | $21.04B -13.4% | $24.29B +6.4% | $22.84B +7.7% | $21.20B -6.4% | $22.65B -5.3% | $23.93B |
| Operating Cash Flow | $1.40B -12.3% | $1.60B +54.7% | $1.03B +241.8% | $-728.0M -151.1% | $1.43B +28.4% | $1.11B |
| Free Cash Flow | $1.00B -20.4% | $1.26B +54.2% | $817.0M +186.4% | $-946.0M -181.8% | $1.16B +43.0% | $809.0M |
Get alerted when BHC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Bausch Health Companies Inc. including:
Top Institutional Holders of BHC
PAULSON & CO. INC.
$361.2M73,255,869 shGOLDENTREE ASSET MANAGEMENT LP
$170.7M34,665,731 shROYAL BANK OF CANADA
$53.4M10,832,582 shHEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
$39.4M8,000,000 shVANGUARD CAPITAL MANAGEMENT LLC
$36.8M7,465,468 shGEODE CAPITAL MANAGEMENT, LLC
$33.2M4,803,485 shGOLDMAN SACHS GROUP INC
$30.7M6,225,131 shMFN Partners Management, LP
$29.6M6,000,000 shSG Americas Securities, LLC
$27.3M5,535,771 shACADIAN ASSET MANAGEMENT LLC
$27.0M5,482,986 sh
| Fund | Value | Shares |
|---|---|---|
| PAULSON & CO. INC. | $361.2M | 73,255,869 |
| GOLDENTREE ASSET MANAGEMENT LP | $170.7M | 34,665,731 |
| ROYAL BANK OF CANADA | $53.4M | 10,832,582 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $39.4M | 8,000,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $36.8M | 7,465,468 |
| GEODE CAPITAL MANAGEMENT, LLC | $33.2M | 4,803,485 |
| GOLDMAN SACHS GROUP INC | $30.7M | 6,225,131 |
| MFN Partners Management, LP | $29.6M | 6,000,000 |
| SG Americas Securities, LLC | $27.3M | 5,535,771 |
| ACADIAN ASSET MANAGEMENT LLC | $27.0M | 5,482,986 |
Companies Similar to BHC
Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.
Bausch & Lomb Corp
Viatris Inc
Elanco Animal Health Inc
PFIZER INC
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
COOPER COMPANIES, INC.
Fortrea Holdings Inc.
Enovis CORP
Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.
More Healthcare Companies
View all Healthcare →Put BHC on your watchlist
Track score changes the day Bausch Health Companies Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is BHC a good stock to buy?
13F Pro's AI-powered analysis of Bausch Health Companies Inc. (BHC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for BHC are available on the BHC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. BHC is classified as a mid company.
Which hedge funds own BHC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling BHC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Bausch Health Companies Inc.'s investment landscape.